Gary Hattersley insider trades: Nuvation Bio (NUVB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | NUVB | ↓ Sell | 100,000 | $7.09 | $709K | Direct | Aug 21, 2026 (2d) |
| Nov 20, 2025 | NUVB | ↓ Sell | 369,051 | $7.23 | $2.7M | Direct | Nov 24, 2025 (4d) |
| Oct 27, 2025 | NUVB | ↓ Sell | 100,000 | $5.02 | $502K | Direct | Oct 29, 2025 (2d) |
| Nov 12, 2015 | RDUS | ↓ Sell | 5,683 | $75.00 | $426K | Direct | Nov 13, 2015 (1d) |
| Nov 3, 2015 | RDUS | ↓ Sell | 13,333 | $70.00 | $933K | Direct | Nov 5, 2015 (2d) |
| Oct 23, 2015 | RDUS | ↓ Sell | 11,302 | $65.00 | $735K | Direct | Oct 27, 2015 (4d) |
| Oct 21, 2015 | RDUS | ↓ Sell | 1,501 | $65.36 | $98K | Direct | Oct 23, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUVB insiders
Open-market trades in the last 12 months
About Gary Hattersley's insider trades
Gary Hattersley is Chief Scientific Officer at Nuvation Bio (NUVB). Since Oct 21, 2015, Gary has reported no open-market purchases and 7 sales worth $6.1M on SEC Form 4. In the last 12 months: 2 sales ($3.4M).
Their filings also include grants and awards (13 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.